EA201790327A1 - Соединения замещенного пиперидина - Google Patents

Соединения замещенного пиперидина

Info

Publication number
EA201790327A1
EA201790327A1 EA201790327A EA201790327A EA201790327A1 EA 201790327 A1 EA201790327 A1 EA 201790327A1 EA 201790327 A EA201790327 A EA 201790327A EA 201790327 A EA201790327 A EA 201790327A EA 201790327 A1 EA201790327 A1 EA 201790327A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted piperidine
connections
compounds
formula
present
Prior art date
Application number
EA201790327A
Other languages
English (en)
Russian (ru)
Inventor
Лорна Хелен Митчелл
Эндрю Саймон Белл
Ричард Чесуорт
Меган Элин Клунан Фоли
Кевин Уэйн Кунц
Джеймс Эдвард Джон Миллс
Майкл Джон Манчхоф
Original Assignee
Эпизим, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эпизим, Инк. filed Critical Эпизим, Инк.
Publication of EA201790327A1 publication Critical patent/EA201790327A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA201790327A 2014-09-10 2015-09-09 Соединения замещенного пиперидина EA201790327A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462048771P 2014-09-10 2014-09-10
US201462078845P 2014-11-12 2014-11-12
US201562146790P 2015-04-13 2015-04-13
PCT/US2015/049235 WO2016040515A1 (en) 2014-09-10 2015-09-09 Substituted piperidine compounds

Publications (1)

Publication Number Publication Date
EA201790327A1 true EA201790327A1 (ru) 2017-10-31

Family

ID=55459535

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790327A EA201790327A1 (ru) 2014-09-10 2015-09-09 Соединения замещенного пиперидина

Country Status (13)

Country Link
US (1) US10577363B2 (enExample)
EP (1) EP3193605A4 (enExample)
JP (1) JP2017528464A (enExample)
KR (1) KR20170047397A (enExample)
CN (1) CN107072207A (enExample)
AU (1) AU2015315182A1 (enExample)
BR (1) BR112017004589A2 (enExample)
CA (1) CA2960280A1 (enExample)
EA (1) EA201790327A1 (enExample)
IL (1) IL250888A0 (enExample)
MX (1) MX2017002986A (enExample)
SG (2) SG11201701597RA (enExample)
WO (1) WO2016040515A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040511A1 (en) 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamides as irreversible smyd inhibitors
CA2960274A1 (en) 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
EP3190891B1 (en) 2014-09-10 2020-01-15 Epizyme, Inc. Isoxazolecarboxamide substituted by a cyclohexylamine as smyd protein inhibitors
AU2015315174B2 (en) 2014-09-10 2019-12-12 Epizyme, Inc. Smyd inhibitors
US10106509B2 (en) * 2015-02-27 2018-10-23 Op Bio Factory Co., Ltd. Method for producing kakeromycin and derivatives thereof
EP3490986B1 (en) 2016-07-28 2021-11-24 Idorsia Pharmaceuticals Ltd Piperidine cxcr7 receptor modulators
WO2018151678A1 (en) * 2017-02-15 2018-08-23 Agency For Science, Technology And Research Compounds for treatment of cancer and epigenetics
KR102502046B1 (ko) * 2018-01-26 2023-02-20 이도르시아 파마슈티컬스 리미티드 Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-{[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노}-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태
JP7425793B2 (ja) 2018-10-29 2024-01-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリジニルスルホンアミド誘導体、医薬組成物およびそれらの使用
CA3112510A1 (en) 2018-10-29 2020-05-07 Boehringer Ingelheim International Gmbh Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
WO2021065898A1 (ja) 2019-09-30 2021-04-08 日本ケミファ株式会社 アゼパン誘導体
CN114702552B (zh) * 2022-03-11 2024-05-31 苏州思萃免疫技术研究所有限公司 mTORC2抑制剂
CN117800895A (zh) * 2022-09-30 2024-04-02 苏州阿尔脉生物科技有限公司 草酸胺类衍生物、包含其的药物组合物及其医药用途
WO2025133989A1 (en) * 2023-12-20 2025-06-26 Alt-Bio Pte. Ltd. Smyd modulators and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1228288B (it) * 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
SE0403106D0 (sv) * 2004-12-20 2004-12-20 Astrazeneca Ab Chemical compounds
WO2008137834A2 (en) * 2007-05-04 2008-11-13 Osi Pharmaceuticals, Inc. Crystal structure of smyd3 protein
WO2009072643A1 (en) * 2007-12-03 2009-06-11 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound and use thereof
TWI535712B (zh) * 2010-08-06 2016-06-01 阿斯特捷利康公司 化合物
PL2651417T3 (pl) * 2010-12-16 2017-08-31 Calchan Limited Pochodne pirolopirymidyny hamujące ASK1
JP2017527577A (ja) 2014-09-10 2017-09-21 エピザイム,インコーポレイティド 置換ピロリジン化合物
WO2016040511A1 (en) 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamides as irreversible smyd inhibitors
AU2015315174B2 (en) 2014-09-10 2019-12-12 Epizyme, Inc. Smyd inhibitors
EP3190891B1 (en) 2014-09-10 2020-01-15 Epizyme, Inc. Isoxazolecarboxamide substituted by a cyclohexylamine as smyd protein inhibitors
CA2960274A1 (en) 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
EP3193609A4 (en) 2014-09-10 2018-02-28 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds

Also Published As

Publication number Publication date
KR20170047397A (ko) 2017-05-04
CA2960280A1 (en) 2016-03-17
JP2017528464A (ja) 2017-09-28
CN107072207A (zh) 2017-08-18
WO2016040515A1 (en) 2016-03-17
US20170362217A1 (en) 2017-12-21
SG11201701597RA (en) 2017-03-30
EP3193605A4 (en) 2018-04-18
BR112017004589A2 (pt) 2018-01-23
EP3193605A1 (en) 2017-07-26
MX2017002986A (es) 2017-10-24
IL250888A0 (en) 2017-04-30
AU2015315182A1 (en) 2017-03-16
SG10201901189SA (en) 2019-03-28
US10577363B2 (en) 2020-03-03

Similar Documents

Publication Publication Date Title
EA201790317A1 (ru) Ингибиторы smyd
CY1125245T1 (el) Ετεροκυκλικες ενωσεις ως αναστολεις ρι3κ-γαμμα
CY1121706T1 (el) Ενωσεις υποκατασταθεισες διυδροϊσοκινολινονης
CY1121334T1 (el) Αναστολεας κινασης aurora a
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA201692079A1 (ru) Ингибиторы лизин-специфической деметилазы-1
MX2017002986A (es) Compuestos de piperidina sustituidos.
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
EA201692513A1 (ru) Ингибиторы лизин-специфической деметилазы-1
EA201791304A1 (ru) Производные изохинолина для лечения вич
EA201790078A1 (ru) Ингибиторы mnk и связанные с ними способы
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
EA201790271A1 (ru) Ингибиторы гликозидазы
EA201790376A1 (ru) Ингибиторы лизин-специфической деметилазы-1
EA201890307A1 (ru) Индазольные и азаиндазольные соединения как ингибиторы irak-4
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201991884A3 (ru) Ингибиторы g12c kras
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA201992320A1 (ru) Пиперидины в качестве ковалентных ингибиторов менина
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
EA201790082A1 (ru) Ингибиторы лизин-специфической демитилазы-1
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции